BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26314472)

  • 1. [Effect of Ikaros in B Cell Acute Lymphoblastic Leukemia].
    Zhang HY; Bai H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Aug; 23(4):1194-8. PubMed ID: 26314472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ikaros and tumor suppression in acute lymphoblastic leukemia.
    Payne KJ; Dovat S
    Crit Rev Oncog; 2011; 16(1-2):3-12. PubMed ID: 22150303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional Regulation of Genes by Ikaros Tumor Suppressor in Acute Lymphoblastic Leukemia.
    Dhanyamraju PK; Iyer S; Smink G; Bamme Y; Bhadauria P; Payne JL; Dovat E; Klink M; Ding Y
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32085659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis and regulation of cellular proliferation in acute lymphoblastic leukemia - the role of Ikaros.
    Wang H; Ouyang H; Lai L; Petrovic-Dovat L; Stankov K; Bogdanovic G; Dovat S
    J BUON; 2014; 19(1):22-8. PubMed ID: 24659638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IKAROS Gene Deleted B-Cell Acute Lymphoblastic Leukemia in Mexican Mestizos: Observations in Seven Patients and a Short Review of the Literature.
    Ruiz-Delgado GJ; Cantero-Fortiz Y; León-Peña AA; León-González M; Nuñez-Cortés AK; Ruiz-Argüelles GJ
    Rev Invest Clin; 2016; 68(4):210-4. PubMed ID: 27623040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of cellular proliferation in acute lymphoblastic leukemia by Casein Kinase II (CK2) and Ikaros.
    Gowda C; Song C; Kapadia M; Payne JL; Hu T; Ding Y; Dovat S
    Adv Biol Regul; 2017 Jan; 63():71-80. PubMed ID: 27666503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IKAROS in Acute Leukemia: A Positive Influencer or a Mean Hater?
    Conserva MR; Redavid I; Anelli L; Zagaria A; Tarantini F; Cumbo C; Tota G; Parciante E; Coccaro N; Minervini CF; Minervini A; Specchia G; Musto P; Albano F
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ikaros regulation of the BCL6/BACH2 axis and its clinical relevance in acute lymphoblastic leukemia.
    Ge Z; Zhou X; Gu Y; Han Q; Li J; Chen B; Ge Q; Dovat E; Payne JL; Sun T; Song C; Dovat S
    Oncotarget; 2017 Jan; 8(5):8022-8034. PubMed ID: 28030830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ikaros Family Zinc Finger 1 Mutation Is an Adverse Prognostic Factor for Patients with Adult B-Cell Acute Lymphoblastic Leukemia].
    Tang SH; Lu Y; Zhang PS; Liu XH; DU XH; Chen D; Pei RZ; Tang XW
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):405-410. PubMed ID: 32319370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ikaros family zinc finger 1 mutation is a poor prognostic factor for adult Philadelphia chromosome positive acute lymphoblastic leukemia].
    Tang SH; Lu Y; Zhang PS; Liu XH; Du XH; Chen D; Li SY; Cao JJ; Chen LG; Le J; Qian SY; Hong YW; Pei RZ
    Zhonghua Nei Ke Za Zhi; 2019 Apr; 58(4):301-306. PubMed ID: 30917424
    [No Abstract]   [Full Text] [Related]  

  • 11. Non-DNA-binding Ikaros isoform gene expressed in adult B-precursor acute lymphoblastic leukemia.
    Nishii K; Katayama N; Miwa H; Shikami M; Usui E; Masuya M; Araki H; Lorenzo F; Ogawa T; Kyo T; Nasu K; Shiku H; Kita K
    Leukemia; 2002 Jul; 16(7):1285-92. PubMed ID: 12094252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superenhancer reprogramming drives a B-cell-epithelial transition and high-risk leukemia.
    Hu Y; Zhang Z; Kashiwagi M; Yoshida T; Joshi I; Jena N; Somasundaram R; Emmanuel AO; Sigvardsson M; Fitamant J; El-Bardeesy N; Gounari F; Van Etten RA; Georgopoulos K
    Genes Dev; 2016 Sep; 30(17):1971-90. PubMed ID: 27664237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IKAROS and CK2 regulate expression of BCL-XL and chemosensitivity in high-risk B-cell acute lymphoblastic leukemia.
    Song C; Ge Z; Ding Y; Tan BH; Desai D; Gowda K; Amin S; Gowda R; Robertson GP; Yue F; Huang S; Spiegelman V; Payne JL; Reeves ME; Gurel Z; Iyer S; Dhanyamraju PK; Xiang M; Kawasawa YI; Cury NM; Yunes JA; McGrath M; Schramm J; Su R; Yang Y; Zhao Z; Lyu X; Muschen M; Payne KJ; Gowda C; Dovat S
    Blood; 2020 Sep; 136(13):1520-1534. PubMed ID: 32396934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haploinsufficiency of the IKZF1 (IKAROS) tumor suppressor gene cooperates with BCR-ABL in a transgenic model of acute lymphoblastic leukemia.
    Virely C; Moulin S; Cobaleda C; Lasgi C; Alberdi A; Soulier J; Sigaux F; Chan S; Kastner P; Ghysdael J
    Leukemia; 2010 Jun; 24(6):1200-4. PubMed ID: 20393504
    [No Abstract]   [Full Text] [Related]  

  • 15. Ikaros induces quiescence and T-cell differentiation in a leukemia cell line.
    Kathrein KL; Lorenz R; Innes AM; Griffiths E; Winandy S
    Mol Cell Biol; 2005 Mar; 25(5):1645-54. PubMed ID: 15713624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic inactivation of Ikaros is a rare event in human T-ALL.
    Marçais A; Jeannet R; Hernandez L; Soulier J; Sigaux F; Chan S; Kastner P
    Leuk Res; 2010 Apr; 34(4):426-9. PubMed ID: 19796813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein signaling and regulation of gene transcription in leukemia: role of the Casein Kinase II-Ikaros axis.
    Gowda CS; Song C; Ding Y; Kapadia M; Dovat S
    J Investig Med; 2016 Mar; 64(3):735-9. PubMed ID: 26912004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1
    Schjerven H; Ayongaba EF; Aghajanirefah A; McLaughlin J; Cheng D; Geng H; Boyd JR; Eggesbø LM; Lindeman I; Heath JL; Park E; Witte ON; Smale ST; Frietze S; Müschen M
    J Exp Med; 2017 Mar; 214(3):793-814. PubMed ID: 28190001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of different Ikaros cDNA transcripts in Philadelphia-positive adult acute lymphoblastic leukemia by a high-throughput capillary electrophoresis sizing method.
    Iacobucci I; Lonetti A; Cilloni D; Messa F; Ferrari A; Zuntini R; Ferrari S; Ottaviani E; Arruga F; Paolini S; Papayannidis C; Piccaluga PP; Soverini S; Saglio G; Pane F; Baruzzi A; Vignetti M; Berton G; Vitale A; Chiaretti S; Müschen M; Foà R; Baccarani M; Martinelli G
    Haematologica; 2008 Dec; 93(12):1814-21. PubMed ID: 18838475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting casein kinase II restores Ikaros tumor suppressor activity and demonstrates therapeutic efficacy in high-risk leukemia.
    Song C; Gowda C; Pan X; Ding Y; Tong Y; Tan BH; Wang H; Muthusami S; Ge Z; Sachdev M; Amin SG; Desai D; Gowda K; Gowda R; Robertson GP; Schjerven H; Muschen M; Payne KJ; Dovat S
    Blood; 2015 Oct; 126(15):1813-22. PubMed ID: 26219304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.